Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart Failure
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 250 participants.
Also called NCT07018297
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 250 participants
- Registry
-
NCT07018297
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07018297. Randomized; no masking; primary purpose treatment. Start 2028-08 (anticipated); primary completion 2028-09-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart Failure
- Condition
- Heart Failure
- Condition
- Acute Decompensated Heart Failure
- Intervention (Combination product)
- Early Discharge with Lasix® ONYU (furosemide injection, for subcutaneous use) using SQIN-Infusor
- Lead sponsor
- University of Texas Southwestern Medical Center
Record details
- Record id
cardio:ct-nct07018297- Content hash
4f7404a6b6896bbbca69f5a5cc97363f015ef32293c8d6987dbdd1c69814f43a